🏥Healthcare Avoidance

Near-universal supplement adoption among Canadian adults demonstrates VMS products are a core pillar of Canadian wellness routines. This high baseline usage suggests a mature market with strong consumer engagement.

82

Score

Bayer's July 2025 launch of Supradyn Naturals Ginseng marks a strategic entry into men-specific supplementation, claiming 10x antioxidant power in a vegetarian, sugar-free format. This represents major pharma investment in gender-targeted nutrition.

82

Score

Newer TRT users report struggling with dialing in dosages, with high estrogen side effects at higher doses causing regret and second-guessing. The trial-and-error process in the first months creates negative experiences that may lead to dropout.

74

Score

After four decades of tracking supplement research, Men's Health magazine cautions consumers that many product claims are overstated, emphasizing need for evidence-based purchasing. This underscores persistent gap between marketing and scientific evidence.

74

Score

US Pharmacist reports significant interest in TRT among younger men, with 14% having used testosterone products. This demonstrates growing demand that may outpace evidence-based clinical indications.

74

Score

Canadian Men's Health Foundation research found men aged 19-29 have higher problem anger risk than average Canadian men. This highlights mental health as a critical dimension of men's health beyond hormonal factors.

74

Score

Public Citizen formally requested the FDA restore boxed warnings for cardiovascular risks on testosterone products and halt expanded indications without independent studies. This reflects ongoing safety concerns among consumer health advocates.

74

Score

Experienced users are advising younger men to simplify their stacks to essentials like Omega-3, Vitamin D3/K2, and magnesium rather than overcomplicating. This counter-trend suggests fatigue with supplement excess and a shift toward sustainable, evidence-based basics.

70

Score

Multiple men across age groups consistently mention magnesium glycinate specifically for sleep quality, anxiety reduction, and muscle recovery, with some rejecting pricier alternatives like L-threonate due to lack of perceived difference. This suggests strong grassroots confidence in this specific form.

70

Score

GNC Holdings introduced Mega Men Ultra Testosterone in June 2023, a science-backed formulation designed to optimize testosterone levels using proprietary delivery technology. This signals continued industry focus on hormone optimization for men's health.

70

Score

On December 10, 2025, the FDA hosted leading experts to evaluate testosterone therapy evidence and potential regulatory changes. This signals possible tightening of TRT oversight in the US market.

64

Score

Men as young as 19-22 are sharing elaborate supplement regimens and seeking peer feedback, indicating anxiety about optimizing health early and reliance on community rather than medical guidance. This reflects a broader trend of self-directed health management among younger males.

52

Score

Men in their early 30s with below-range testosterone are turning to Reddit communities for reassurance and real-world experiences before medical consultations, indicating distrust or uncertainty about clinical guidance alone.

52

Score

Following its ZAVA acquisition, Hims & Hers will enter Canada in 2026, timing expansion with generic semaglutide availability for obesity treatment. This signals growing integration of digital health platforms with men's supplement offerings.

52

Score